These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16908420

  • 1. Evaluation and comparison of physicomechanical characteristics of gelatin and hypromellose capsules.
    Missaghi S, Fassihi R.
    Drug Dev Ind Pharm; 2006 Aug; 32(7):829-38. PubMed ID: 16908420
    [Abstract] [Full Text] [Related]

  • 2. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y, Nazzal S, Bottom CB.
    Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
    [Abstract] [Full Text] [Related]

  • 3. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M, Rothenhäusler B, Röthlisberger D.
    Drug Dev Ind Pharm; 2006 Jan; 32(10):1165-73. PubMed ID: 17090439
    [Abstract] [Full Text] [Related]

  • 4. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Jan; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 5. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 Jan; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
    Birchall JC, Jones BE, Morrissey A, Jones BE.
    Drug Dev Ind Pharm; 2008 Aug; 34(8):870-6. PubMed ID: 18686093
    [Abstract] [Full Text] [Related]

  • 7. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.
    Jones BE, Basit AW, Tuleu C.
    Int J Pharm; 2012 Mar 15; 424(1-2):40-3. PubMed ID: 22214655
    [Abstract] [Full Text] [Related]

  • 8. The shell dissolution of various empty hard capsules.
    Chiwele I, Jones BE, Podczeck F.
    Chem Pharm Bull (Tokyo); 2000 Jul 15; 48(7):951-6. PubMed ID: 10923822
    [Abstract] [Full Text] [Related]

  • 9. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D, Bindra DS.
    Pharm Dev Technol; 2007 Jul 15; 12(1):71-7. PubMed ID: 17484146
    [Abstract] [Full Text] [Related]

  • 10. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
    Curatolo W, Liu P, Johnson BA, Hausberger A, Quan E, Vendola T, Vatsaraj N, Foulds G, Vincent J, Chandra R.
    Pharm Res; 2011 Jul 15; 28(7):1531-9. PubMed ID: 21331473
    [Abstract] [Full Text] [Related]

  • 11. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F, Jones BE.
    Drug Dev Ind Pharm; 2002 Oct 15; 28(9):1163-9. PubMed ID: 12455475
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET, Scott RA, Cade D, Connor AL, Wilding IR.
    Pharm Res; 2004 May 15; 21(5):793-8. PubMed ID: 15180336
    [Abstract] [Full Text] [Related]

  • 13. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K.
    Int J Pharm; 2010 Feb 15; 386(1-2):30-41. PubMed ID: 19900518
    [Abstract] [Full Text] [Related]

  • 14. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C, Khela MK, Evans DF, Jones BE, Nagata S, Basit AW.
    Eur J Pharm Sci; 2007 Mar 15; 30(3-4):251-5. PubMed ID: 17188473
    [Abstract] [Full Text] [Related]

  • 15. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS, Lu Q, Li W, Chen Y.
    Int J Pharm; 2011 Sep 15; 416(1):16-24. PubMed ID: 21356291
    [Abstract] [Full Text] [Related]

  • 16. HPMC capsules: current status and future prospects.
    Al-Tabakha MM.
    J Pharm Pharm Sci; 2010 Sep 15; 13(3):428-42. PubMed ID: 21092714
    [Abstract] [Full Text] [Related]

  • 17. Gelatin and Non-Gelatin Capsule Dosage Forms.
    Gullapalli RP, Mazzitelli CL.
    J Pharm Sci; 2017 Jun 15; 106(6):1453-1465. PubMed ID: 28209365
    [Abstract] [Full Text] [Related]

  • 18. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M, Bodmeier R.
    Eur J Pharm Biopharm; 2006 Feb 15; 62(2):178-84. PubMed ID: 16260126
    [Abstract] [Full Text] [Related]

  • 19. "Performance qualification of a new hypromellose capsule. Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules and Part II. Disintegration and dissolution comparison between two types of hypromellose capsules" by M. Sherry Ku et al.
    Jones BE, Podczeck F.
    Int J Pharm; 2012 Feb 28; 423(2):589-92. PubMed ID: 22155286
    [No Abstract] [Full Text] [Related]

  • 20. Effect of formulation conditions on hypromellose performance properties in films used for capsules and tablet coatings.
    Curtis-Fisk J, Sheskey P, Balwinski K, Coppens K, Mohler C, Zhao J.
    AAPS PharmSciTech; 2012 Dec 28; 13(4):1170-8. PubMed ID: 22961412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.